Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.44 |
| ▸ | SNCA | P37840 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9726535 | 0.79 | HMGCR (0.46) | HMGCRALDH1A1 | |
| SCHEMBL9235124 | 0.79 | HMGCR (0.46) | HMGCRALDH1A1 | |
| SCHEMBL9726875 | 0.77 | HMGCR (0.45) | HMGCRALDH1A1PKM | |
| SCHEMBL9233023 | 0.76 | HMGCR (0.44) | HMGCRALDH1A1 | |
| SCHEMBL9726579 | 0.71 | HMGCR (0.43) | HMGCRALDH1A1 | |
| SCHEMBL9235476 | 0.71 | HMGCR (0.46) | HMGCRALDH1A1 | |
| SCHEMBL9726697 | 0.71 | HMGCR (0.52) | HMGCRALDH1A1HSD11B1PKM | |
| SCHEMBL9726705 | 0.71 | HMGCR (0.52) | HMGCRALDH1A1HSD11B1PKM | |
| SCHEMBL9726690 | 0.71 | HMGCR (0.52) | HMGCRALDH1A1HSD11B1PKM | |
| SCHEMBL9726582 | 0.71 | HMGCR (0.42) | HMGCRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4939265-A | Intermediates and process for the preparation of antihypercholesterolemic tetrazole compounds | BRISTOL-MYERS COMPANY (US) | 1990-07-03 | — | — | US | claimed |
| US-5110940-A | Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase | BRISTOL-MYERS COMPANY (US) | 1992-05-05 | — | — | US | disclosed |
| US-5068346-A | Anticholesterol agents | BRISTOL-MYERS COMPANY (US) | 1991-11-26 | — | — | US | disclosed |
| US-4939265-A | Intermediates and process for the preparation of antihypercholesterolemic tetrazole compounds | BRISTOL-MYERS COMPANY (US) | 1990-07-03 | — | — | US | disclosed |
| US-4898949-A | Intermediates for the preparation of antihypercholesterolemic tetrazole compounds | BRISTOL-MYERS COMPANY (US) | 1990-02-06 | — | — | US | disclosed |
| US-4898950-A | Preparation of antihypercholesterolemic tetrazole compounds | BRISTOL-MYERS COMPANY (US) | 1990-02-06 | — | — | US | disclosed |
| US-4897490-A | DERIVATIVES OF BETA-HYDROXY,OMEGA-DIPHENYL,TETRAZOL-5-YL ALK-OMEGA-ENOIC ACID, ESTER OR LACTONE | BRISTOL-MEYERS COMPANY (US) | 1990-01-30 | — | — | US | disclosed |
| US-4824959-A | Intermediates for antihypercholesterolemic tetrazole compounds | BRISTOL-MYERS COMPANY (US) | 1989-04-25 | — | — | US | disclosed |